Danaher Corporation
In the published model solve dated 2026-Q2, anchored at $216.07, Danaher Corporation (DHR) is priced for +24.0% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed July 25, 2026 from SEC EDGAR filings.
• Consumables, services and other repeat business made up $20.1 billion of $24.6 billion in 2025 revenue and grew from $19.4 billion, while one-time equipment sales shrank [Source: FY2025 Form 10-K]. • Trailing return on equity of 7.0% sits below the roughly nine percent that equity investors require of a business like this, which is the single fact behind why no standard valuation frame reaches today's price. • A signed agreement to buy Masimo for roughly 9.9 billion dollars, dated February 16,
Is DHR overvalued? See what's priced in →
2,109 institutional managers reported holding DHR in 13F filings for the quarter ended 2026-03-31. Together they hold about 77% of the company; the top 10 hold 34%. 134 opened new positions that quarter. Held by Vanguard Group, BlackRock, State Street, among others. On the short side, 11.5M shares were sold short as of the 2026-06-15 count, about 2% of shares outstanding (2.9 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
DHR has cut its share count 12.2% over the past five years, spending $9.07B on repurchases. It pays a dividend, and has paid one every year in our records (18 and counting), raised 12 years straight. Cash returned over the past three years: $2.27B in dividends and $9.07B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at DHR over the trailing three years. Absence is a fact about the company, not a signal. 25 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
DHR's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-07-26 | +2.7% | -6.6% |
| 2023-10-25 | -5.6% | +20.9% |
| 2024-02-22 | +3.1% | -2.7% |
| 2024-04-24 | +6.1% | +1.3% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
DHR's latest 8-K filings: 2026-08-03 (items 5.02, 7.01, 8.01, 9.01); 2026-07-21 (items 2.02, 9.01); 2026-06-03 (items 2.03, 8.01); 2026-05-07 (items 5.02, 5.07, 9.01); 2026-04-29 (items 1.01, 8.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 25, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.